Cargando…
Ginseng: A bibliometric analysis of 40-year journey of global clinical trials
BACKGROUND: Ginseng has a long history of widespread use and remarkable effects as traditional medicine, adjuvant and dietary supplement. The therapeutic value, diverse functionalities and rapid development of ginseng have driven a significant increase in the number of ginseng clinical trials, rangi...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8655123/ https://www.ncbi.nlm.nih.gov/pubmed/35024190 http://dx.doi.org/10.1016/j.jare.2020.07.016 |
_version_ | 1784612016024977408 |
---|---|
author | Chen, Weijie Yao, Peifen Vong, Chi Teng Li, Xiuzhu Chen, Zhejie Xiao, Jianbo Wang, Shengpeng Wang, Yitao |
author_facet | Chen, Weijie Yao, Peifen Vong, Chi Teng Li, Xiuzhu Chen, Zhejie Xiao, Jianbo Wang, Shengpeng Wang, Yitao |
author_sort | Chen, Weijie |
collection | PubMed |
description | BACKGROUND: Ginseng has a long history of widespread use and remarkable effects as traditional medicine, adjuvant and dietary supplement. The therapeutic value, diverse functionalities and rapid development of ginseng have driven a significant increase in the number of ginseng clinical trials, ranging from its use in various ailments, formulation to safety concerns. Despite the persistent interest in ginseng clinical research, the medical effectiveness of ginseng is inconclusive and there is a lack of bibliometric analysis of the hundreds of ginseng clinical trials. AIM OF REVIEW: This review aims to provide an extensive overview of ginseng clinical trials over the past 40 years (1979-2018) in combination with a qualitative and quantitative analysis. The annual clinical trial analysis of time distribution, country and institution network analysis for space cooperation, statistical analysis for various functions, as well as efficiency and effect size were performed for global ginseng clinical trials. Besides, preparation categories, administration routes, and the safety of ginseng clinical trials were also investigated. KEY SCIENTIFIC CONCEPTS OF REVIEW: The 40-year journey of ginseng clinical trials has experienced emerging, boom, and stable or transitional stages. The global network of ginseng clinical trials has relevant regional distribution in Asia, North America and Europe. South Korea makes a great contribution to building up large research clusters and strong cooperation links. Universities are the key contributors to ginseng clinical trials. The development of ginseng products could be focused on the clinical trial in diseases with higher effectiveness or effect size, such as sexual function and cognitive & behavior and require rigorous investigations and evidence to evaluate safety. More attention should be paid to different effects from different preparations. We believe this review will provide new insights into the understanding of global ginseng clinical trials and identifies potential future perspectives for research and development of ginseng. |
format | Online Article Text |
id | pubmed-8655123 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-86551232022-01-11 Ginseng: A bibliometric analysis of 40-year journey of global clinical trials Chen, Weijie Yao, Peifen Vong, Chi Teng Li, Xiuzhu Chen, Zhejie Xiao, Jianbo Wang, Shengpeng Wang, Yitao J Adv Res Article BACKGROUND: Ginseng has a long history of widespread use and remarkable effects as traditional medicine, adjuvant and dietary supplement. The therapeutic value, diverse functionalities and rapid development of ginseng have driven a significant increase in the number of ginseng clinical trials, ranging from its use in various ailments, formulation to safety concerns. Despite the persistent interest in ginseng clinical research, the medical effectiveness of ginseng is inconclusive and there is a lack of bibliometric analysis of the hundreds of ginseng clinical trials. AIM OF REVIEW: This review aims to provide an extensive overview of ginseng clinical trials over the past 40 years (1979-2018) in combination with a qualitative and quantitative analysis. The annual clinical trial analysis of time distribution, country and institution network analysis for space cooperation, statistical analysis for various functions, as well as efficiency and effect size were performed for global ginseng clinical trials. Besides, preparation categories, administration routes, and the safety of ginseng clinical trials were also investigated. KEY SCIENTIFIC CONCEPTS OF REVIEW: The 40-year journey of ginseng clinical trials has experienced emerging, boom, and stable or transitional stages. The global network of ginseng clinical trials has relevant regional distribution in Asia, North America and Europe. South Korea makes a great contribution to building up large research clusters and strong cooperation links. Universities are the key contributors to ginseng clinical trials. The development of ginseng products could be focused on the clinical trial in diseases with higher effectiveness or effect size, such as sexual function and cognitive & behavior and require rigorous investigations and evidence to evaluate safety. More attention should be paid to different effects from different preparations. We believe this review will provide new insights into the understanding of global ginseng clinical trials and identifies potential future perspectives for research and development of ginseng. Elsevier 2020-07-30 /pmc/articles/PMC8655123/ /pubmed/35024190 http://dx.doi.org/10.1016/j.jare.2020.07.016 Text en © 2021 The Authors. Published by Elsevier B.V. on behalf of Cairo University. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Article Chen, Weijie Yao, Peifen Vong, Chi Teng Li, Xiuzhu Chen, Zhejie Xiao, Jianbo Wang, Shengpeng Wang, Yitao Ginseng: A bibliometric analysis of 40-year journey of global clinical trials |
title | Ginseng: A bibliometric analysis of 40-year journey of global clinical trials |
title_full | Ginseng: A bibliometric analysis of 40-year journey of global clinical trials |
title_fullStr | Ginseng: A bibliometric analysis of 40-year journey of global clinical trials |
title_full_unstemmed | Ginseng: A bibliometric analysis of 40-year journey of global clinical trials |
title_short | Ginseng: A bibliometric analysis of 40-year journey of global clinical trials |
title_sort | ginseng: a bibliometric analysis of 40-year journey of global clinical trials |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8655123/ https://www.ncbi.nlm.nih.gov/pubmed/35024190 http://dx.doi.org/10.1016/j.jare.2020.07.016 |
work_keys_str_mv | AT chenweijie ginsengabibliometricanalysisof40yearjourneyofglobalclinicaltrials AT yaopeifen ginsengabibliometricanalysisof40yearjourneyofglobalclinicaltrials AT vongchiteng ginsengabibliometricanalysisof40yearjourneyofglobalclinicaltrials AT lixiuzhu ginsengabibliometricanalysisof40yearjourneyofglobalclinicaltrials AT chenzhejie ginsengabibliometricanalysisof40yearjourneyofglobalclinicaltrials AT xiaojianbo ginsengabibliometricanalysisof40yearjourneyofglobalclinicaltrials AT wangshengpeng ginsengabibliometricanalysisof40yearjourneyofglobalclinicaltrials AT wangyitao ginsengabibliometricanalysisof40yearjourneyofglobalclinicaltrials |